Genomics – Thematic Intelligence
All the vital news, analysis, and commentary curated by our industry experts.
Genomics Market Thematic Report Overview
Genomics refers to the study of an entire set of DNA within an organism. This includes researching their molecular components, structures, and functions of genes, and developing technologies that map and edit sequences of DNA. Direct-to-consumer genetic testing (DTC-GT) has been a rapidly expanding market that continues to generate substantial amounts of revenue and public interest. The rapid growth of the market has historically been accompanied by regulatory limitations on the extent of consumer health information these services can provide.
The genomics market thematic intelligence report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
|Key Trends||Technology Trends, Macroeconomic Trends, and Regulatory Trends|
|Key Layers of the Value Chain||Technology, DTC Genetic Tests Service Providers, and Third Party Data Re-Analysis of Individuals’ Genetic Information|
|Key Public Companies||23andMe, Illumina, OraSure Technologies, Qiagen, and Thermo Fisher Scientific|
|Key Private Companies||Ancestry.com, FamilyTreeDNA, Helix OpCo, LiveWello, MyHeritage, Orig3N, and Pathway Genomics|
The main trends shaping the genomics industry are classified into technology trends, macroeconomic trends, and regulatory trends.
Technology Trends: The key technology trends impacting the theme are the switch from using the Illumina OmniExpress chip to a customized Illumina global screening array (GSA) microarray, the shift from SNP-BeadArray chips to NGS, the role of social media, privacy, and security concerns, and result accuracy. For instance, one of the most popular SNP-BeadArray devices previously utilized by DTC-GT companies is the Illumina OmniExpress chip. This product was employed by 23andMe, Ancestry.com, MyHeritage, and FamilyTreeDNA. In 2017, 23andMe switched from using the Illumina OmniExpress chip to a customized Illumina Global Screening Array (GSA) microarray. More recently, MyHeritage, and FamilyTreeDNA also switched to using the newer GSA product. It should be noted that MyHeritage DNA samples are processed in the FamilyTreeDNA laboratory, meaning that the two companies are linked in terms of the underlying technology.
Macroeconomic Trends: The impact of COVID-19 pandemic and the growing pace of mergers & acquisitions in the genomics landscape are the key macroeconomic trends explained in the report.
Regulatory Trends: The key regulatory trends explained in the report are, FDA classified DTC- GTs as class II medical devices, Laboratory- developed tests (LDTs) sold with physician oversight, FDA exempts subsequent genetic testing devices from 510(k) premarket approval, FDA exempts subsequent genetic testing devices from 510(k) premarket approval, and Genetic Information Nondiscrimination Act, US.
Genomics Value Chain Analysis
The genomics value chain comprises of three different components: the underlying technology, DTC-GT service providers and third party re-analysis of individuals’ generic information.
The technology underlying this market consists primarily of SNP-BeadArray chips, with DNA collection tubes and next- generation sequencing reagents also being important factors.
Most of these products are sold as class II medical devices, laboratory-developed tests, or do not require FDA premarket approval. As such, pre-clinical/clinical trials are not needed and there are fewer regulatory barriers to market access. DTC-GT service providers perform analysis across a range of different market sectors such as genetic health risks, carrier screening, traits and wellness, and ancestry.
Genomics Value Chain Analysis
For more insights on the genomics value chain, download a free report sample
Leading Public Companies in the Genomics Theme
Some of the leading public companies in the genomics theme are:
- OraSure Technologies
- Thermo Fisher Scientific
Leading Private Companies in the Genomics Theme
Some of the leading private companies in the genomics theme are:
- Helix OpCo
- Pathway Genomics
For more insights on the public and private companies impacting the genomics theme, download a free report sample
Medical Devices Sector Scorecard
At GlobalData, we use a scorecard approach to predict tomorrow’s leading companies within each sector. Our sector scorecard has three screens: a thematic screen, a valuation screen, and a risk screen.
- The thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
- The valuation screen ranks our universe of companies within a sector based on selected valuation metrics.
- The risk screen ranks companies within a particular sector based on overall investment risk.
Medical Devices Sector Scorecard – Thematic Screen
For more insights on the sector scorecards, download a free report sample
- This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
- The report covers the genomics theme.
This report explores genomics products in the direct-to-consumer sector, as well as providing an industry analysis on the market and competitive landscape.
Reasons to Buy
- GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
- Develop and design your corporate strategies through an in-house expert analysis of genomics by understanding the primary ways in which this theme is impacting the healthcare industry.
- Stay up to date on the industry’s major players and where they sit in the value chain.
- Identify emerging industry trends to gain a competitive advantage.
Thermo Fisher Scientific
Map My Gene
Table of Contents
- 1. Executive Summary
- 2. Players
- 3. Technology Briefing
- 4. Trends
- 4.1. Technology trends
- 4.2. Macroeconomic trends
- 4.3. Regulatory trends
- 5. Industry Analysis
- 5.1. Mergers and acquisitions
- 5.2. Venture financing
- 5.3. Patent trends
- 5.4. Company filings trends
- 5.5. Hiring trends
- 5.6. Social media trends
- 5.7. Timeline
- 6. Value Chain
- 6.1. Technology
- 6.2. Service providers
- 6.3. Third-party data re-analysis
- 7. Companies
- 8. Sector Scorecard
- 8.1. Medical devices sector scorecard
- 9. Glossary
- 10. Further Reading
- 11. Our Thematic Research Methodology
- 12. About GlobalData
- 13. Contact Us
Frequently asked questions
What are the components of the genomics value chain?
The genomics value chain comprises of technology, DTC-GT service providers, and third party data re-analysis of individuals’ genetic information.
Which are the leading public companies associated with genomics?
Some of the leading public companies in genomics are 23andMe, Illumina, OraSure Technologies, Qiagen, and Thermo Fisher Scientific.
Which are the leading private companies associated with genomics?
Some of the leading vendors in Genomics are Ancestry.com, FamilyTreeDNA, Helix OpCo, LiveWello, MyHeritage, Orig3N, and Pathway Genomics.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.